Insider Transactions in Q4 2022 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
4,539
-1.34%
|
$4,539
$1.99 P/Share
|
|
Dec 21
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
7,007
-1.69%
|
$7,007
$1.99 P/Share
|
|
Dec 21
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
23,489
-1.91%
|
$23,489
$1.99 P/Share
|
|
Dec 21
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,750
-1.03%
|
$6,750
$1.99 P/Share
|
|
Dec 21
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
15,750
-1.29%
|
$15,750
$1.99 P/Share
|
|
Dec 20
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+4.23%
|
-
|
|
Dec 20
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+3.49%
|
-
|
|
Dec 20
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+4.09%
|
-
|
|
Dec 20
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+3.31%
|
-
|
|
Dec 20
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+3.54%
|
-
|
|
Dec 13
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
31,891
-2.63%
|
$31,891
$1.96 P/Share
|
|
Dec 13
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
18,177
-5.3%
|
$18,177
$1.96 P/Share
|
|
Dec 13
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
23,584
-5.57%
|
$23,584
$1.96 P/Share
|
|
Dec 13
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
61,919
-4.99%
|
$61,919
$1.96 P/Share
|
|
Dec 13
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,253
-0.97%
|
$6,253
$1.96 P/Share
|
|
Dec 12
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
19,484
-1.58%
|
$19,484
$1.98 P/Share
|
|
Dec 12
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
11,105
-3.14%
|
$11,105
$1.98 P/Share
|
|
Dec 12
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
14,410
-3.29%
|
$14,410
$1.98 P/Share
|
|
Dec 12
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
37,831
-2.96%
|
$37,831
$1.98 P/Share
|
|
Dec 12
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
3,820
-0.59%
|
$3,820
$1.98 P/Share
|
|
Oct 28
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
4,563
-0.7%
|
$13,689
$3.47 P/Share
|
|
Oct 28
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
6,000
-0.48%
|
$18,000
$3.47 P/Share
|
|
Oct 28
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
3,516
-0.98%
|
$10,548
$3.47 P/Share
|
|
Oct 28
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
4,382
-0.99%
|
$13,146
$3.47 P/Share
|
|
Oct 28
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
8,805
-0.68%
|
$26,415
$3.47 P/Share
|
|
Oct 25
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+2.37%
|
-
|
|
Oct 25
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
8,500
+2.32%
|
-
|
|
Oct 25
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
9,250
+2.05%
|
-
|
|
Oct 25
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+2.28%
|
-
|
|
Oct 25
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+2.26%
|
-
|